 |
CCO Neuroscience PodcastAuthor: Clinical Care Options
Updates on new data and best practices in patient care across a wide variety of psychiatric and neurological illnesses from Clinical Care Options. Gain a deeper understanding and practical clinical insights on topics ranging from bipolar depression to Parkinsons disease psychosis. Select episodes available for CME/CE credit. Language: en Genres: Courses, Education, Life Sciences, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Cognitive Conversations: Key Findings on Alzheimer’s Disease Presented at CTAD
Episode 42
Tuesday, 23 December, 2025
In this episode of “Cognitive Conversations,” expert faculty discuss breaking data presentations from the 2026 Clinical Trials on Alzheimer’s Disease conference held in San Diego, California, from December 1-4, 2025, and their implications for clinical practice.Topics covered include:Evoke and evoke+ phase III trials of semaglutideSubcutaneous lecanemab as initiation and maintenance treatmentBlood-based biomarker assaysTrontinemab and other brain shuttlesTau targeting therapies in developmentPreventive impact of BCG and herpes zoster vaccinationThis podcast episode is part of the CME/CE-accredited program, “Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages,” supported by an educational grant from Novo Nordisk. Faculty:Anton P. Porsteinsson, MD William B. and Sheila Konar Professor of Psychiatry, Neurology, and Neuroscience, and MedicineDirector, Alzheimer's Disease Care, Research and Education Program (AD-CARE)University of Rochester School of Medicine and DentistryRochester, New YorkVijay K. Ramanan, MD, PhDConsultant and Associate ProfessorDirector, Alzheimer’s Disease Treatment ClinicDepartment of NeurologyMayo ClinicRochester, Minnesota Link to obtain CME/CE credit: https://bit.ly/4999otE Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
